Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Controlling the immune reaction: Research project aims at developing a substance to boost or suppress the immune response

15.04.2010
A new research project led by Sebastian Springer, Professor of Biochemistry and Cell Biology at Jacobs University, is examining how the body's immune reaction to viruses, bacteria and cancer can be manipulated.

In cooperation with Martin Zacharias, Professor of Theoretical Biophysics at the TU Munich, Springer aims at developing chemical substances to inhibit or enhance the response. These substances could be used either in vaccines to boost the immune reaction or in drugs administered to transplant patients to suppress a possible rejection of the organ. The project is funded by the German Research Foundation (DFG) with a total of 225 000 Euros over an initial three-year period.

Vaccination to prevent diseases such as polio and seasonal influenza is commonplace in Europe today. Just a little needle-prick and one is protected from infections like flue or measles. Weakened or killed forms of the pathogen (the virus or bacterium) are contained in the vaccine to stimulate the body's immune response. White blood cells recognize the pathogen as foreign, destroy it, and remember its structure to be able to identify and kill the same kind of virus when encountered again. These facts have been known for a while. However, the chemical processes that take place inside each cell to trigger the immune reaction are still not understood in detail.

For almost ten years, Sebastian Springer, Jacobs University Professor of Biochemistry and Cell Biology, has been conducting research to better understand and influence these processes. His research focuses on the so called "major histocompatibility complex (MHC) class I molecules", which play a central role in the mammalian immune defense against viruses, intracellular bacteria, and cancer.

As a virus replicates inside a cell, it produces peptides (small pieces of proteins). These peptides bind to MHC class I molecules, which are present inside all cells. The binding process activates the molecule to travel to the cell surface, where they are surveyed by white blood cells called "cytotoxic T lymphocytes" (CTL). If the CTL detect that unusual peptides are bound to the molecules, they induce the infected cell to undergo controlled cell death. This way, the production site of the virus is eliminated and it can't spread out further.

During his studies, Springer discovered a chemical substance that enhances the binding process between MHC class I molecules and peptides. "Picture the part of the molecule that the peptide docks onto as the mouth of a venus flytrap," Springer explains. "The substance we discovered is able to keep this mouth - the binding site - open and thus makes it much easier for the peptide to bind to the molecule. As the binding rate increases, more molecules are triggered to travel to the cell surface and an infected cell can be faster detected and eliminated."

Although highly unstable and not yet ready for use in vaccines or other drugs, the newly discovered substance provides an ideal basis for further research. "By understanding how the substance keeps the binding site open we can begin to develop similar but more stable substances for the use in therapeutic drugs," says Springer.

Combining bioinformatics and biochemistry approaches, Springer and his team will develop and analyze various chemical components in respect of their influence on the peptide-molecule binding process. In a first step, Martin Zacharias, Professor of Theoretical Biophysics at the TU Munich, will recreate the chemical structure of the substances in a computer simulation and imitate a possible interaction between substance and molecule. In a second step, the substances that accelerated or retarded the binding process will then be tested in living cells in Springer's laboratory and further developed.

"If we find a chemical substance that is stable enough to travel into cells when administered in combination with a vaccine or other drug," says Springer, "we could be able to control the immune reaction on a cellular level and thus enhance the affectivity of viral vaccination or, by suppressing the immune reaction, increase the success rate of organ transplantations and therapies used for autoimmune disease patients."

Contact at Jacobs University:
Prof Sebastian Springer | Professor of Biochemistry and Cell Biology
https://www.jacobs-university.de/directory/sspringer
Phone: +49 421 200-3243 | E-Mail: s.springer@jacobs-university.de

Dr. Kristin Beck | idw
Further information:
http://www.jacobs-university.de/directory/sspringer

More articles from Life Sciences:

nachricht Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View
22.06.2018 | University of Sussex

nachricht New cellular pathway helps explain how inflammation leads to artery disease
22.06.2018 | Cedars-Sinai Medical Center

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Temperature-controlled fiber-optic light source with liquid core

In a recent publication in the renowned journal Optica, scientists of Leibniz-Institute of Photonic Technology (Leibniz IPHT) in Jena showed that they can accurately control the optical properties of liquid-core fiber lasers and therefore their spectral band width by temperature and pressure tuning.

Already last year, the researchers provided experimental proof of a new dynamic of hybrid solitons– temporally and spectrally stationary light waves resulting...

Im Focus: Overdosing on Calcium

Nano crystals impact stem cell fate during bone formation

Scientists from the University of Freiburg and the University of Basel identified a master regulator for bone regeneration. Prasad Shastri, Professor of...

Im Focus: AchemAsia 2019 will take place in Shanghai

Moving into its fourth decade, AchemAsia is setting out for new horizons: The International Expo and Innovation Forum for Sustainable Chemical Production will take place from 21-23 May 2019 in Shanghai, China. With an updated event profile, the eleventh edition focusses on topics that are especially relevant for the Chinese process industry, putting a strong emphasis on sustainability and innovation.

Founded in 1989 as a spin-off of ACHEMA to cater to the needs of China’s then developing industry, AchemAsia has since grown into a platform where the latest...

Im Focus: First real-time test of Li-Fi utilization for the industrial Internet of Things

The BMBF-funded OWICELLS project was successfully completed with a final presentation at the BMW plant in Munich. The presentation demonstrated a Li-Fi communication with a mobile robot, while the robot carried out usual production processes (welding, moving and testing parts) in a 5x5m² production cell. The robust, optical wireless transmission is based on spatial diversity; in other words, data is sent and received simultaneously by several LEDs and several photodiodes. The system can transmit data at more than 100 Mbit/s and five milliseconds latency.

Modern production technologies in the automobile industry must become more flexible in order to fulfil individual customer requirements.

Im Focus: Sharp images with flexible fibers

An international team of scientists has discovered a new way to transfer image information through multimodal fibers with almost no distortion - even if the fiber is bent. The results of the study, to which scientist from the Leibniz-Institute of Photonic Technology Jena (Leibniz IPHT) contributed, were published on 6thJune in the highly-cited journal Physical Review Letters.

Endoscopes allow doctors to see into a patient’s body like through a keyhole. Typically, the images are transmitted via a bundle of several hundreds of optical...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Munich conference on asteroid detection, tracking and defense

13.06.2018 | Event News

2nd International Baltic Earth Conference in Denmark: “The Baltic Sea region in Transition”

08.06.2018 | Event News

ISEKI_Food 2018: Conference with Holistic View of Food Production

05.06.2018 | Event News

 
Latest News

Graphene assembled film shows higher thermal conductivity than graphite film

22.06.2018 | Materials Sciences

Fast rising bedrock below West Antarctica reveals an extremely fluid Earth mantle

22.06.2018 | Earth Sciences

Zebrafish's near 360 degree UV-vision knocks stripes off Google Street View

22.06.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>